2687 — CVS Bay Area Balance Sheet
0.000.00%
- ¥3bn
- ¥7bn
- ¥8bn
- 24
- 84
- 23
- 38
Annual balance sheet for CVS Bay Area, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,936 | 1,733 | 1,772 | 1,886 | 1,782 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 629 | 488 | 602 | 674 | 633 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,739 | 2,348 | 2,557 | 2,731 | 2,559 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,339 | 4,040 | 3,223 | 4,271 | 5,408 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,508 | 9,407 | 8,680 | 10,281 | 11,266 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,646 | 3,178 | 2,918 | 2,954 | 2,942 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,788 | 6,572 | 5,935 | 6,922 | 6,887 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,719 | 2,834 | 2,744 | 3,359 | 4,379 |
| Total Liabilities & Shareholders' Equity | 10,508 | 9,407 | 8,680 | 10,281 | 11,266 |
| Total Common Shares Outstanding |